Viewing profile — dzhu

"It's remarkable that non [sic] of the investor or regulators paid half as much of attention." Actually, the regulators paid just as much, if not more attention to Theranos - the a…

Benchling's awesome - definitely a well-designed (and much needed!) tool for biologists. They've done a great job with adding new features, from CRISPR design to gel analysis, and …

Actually, they DID collect clinical response data even though it was a Phase Ib trial. Specifically, as the NYT piece mentions, they measured both cognitive function (via the mini-…

They chose to encode one bit per base (rather than two) to give them flexibility in encoding the binary values to avoid particularly tricky sequences for DNA synthesis or sequencin…

"Then you repeat the test." What if the test is inherently flawed? "look at what this drug did to my grandma" Uh, that is purely anecdotal, n of 1 data, which is not scientifically…

Warfarin sensitivity is _precisely_ why 23andMe needs to be regulated; 23andMe has NOT clinically (or analytically) validated any of the claims around the specific SNPs they've ide…

Ah, this is the original article (everything else uses this source as their reference). I forgot that my university has a Science subscription; I'll change it to the abstract, whic…